Lista de obras - Erika Vacchelli - Dominio Público Uruguay

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

artículo científico publicado en 2020

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

scientific article published on 07 September 2019

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy

artículo científico publicado en 2013

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

artículo científico publicado en 2012

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

artículo científico publicado en 2013

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

artículo científico publicado en 2015

Autophagy induction for the treatment of cancer

artículo científico publicado en 2016

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

artículo científico publicado en 2011

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

artículo científico publicado en 2016

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

artículo científico publicado en 2014

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

artículo científico publicado en 2012

Cell death signaling and anticancer therapy

artículo científico publicado en 2011

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

artículo científico publicado en 2015

Classification of current anticancer immunotherapies

artículo científico publicado en 2014

Coffee induces autophagy in vivo

artículo científico publicado en 2014

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

artículo científico publicado en 2016

Contribution of annexin A1 to anticancer immunosurveillance

scientific article published on 14 August 2019

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Crosstalk between ER stress and immunogenic cell death

artículo científico publicado en 2013

Current trends of anticancer immunochemotherapy

artículo científico publicado en 2013

Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses

artículo científico publicado en 2013

Fluorescent biosensors for the detection of HMGB1 release

artículo científico publicado en 2013

Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

artículo científico publicado en 2013

Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells

artículo científico publicado en 2015

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy

artículo científico publicado en 2016

Independent transcriptional reprogramming and apoptosis induction by cisplatin

artículo científico publicado en 2012

Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

artículo científico publicado en 2016

Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer

artículo científico publicado en 2012

Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo

artículo científico publicado en 2015

Mitochondrial gateways to cancer

artículo científico publicado en 2009

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

artículo científico publicado en 2015

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

artículo científico publicado en 2015

No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19

artículo científico publicado en 2020

Organs on chip approach: a tool to evaluate cancer -immune cells interactions

artículo científico publicado en 2017

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

artículo científico publicado en 2012

Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins

artículo científico publicado en 2012

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

article

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Regulation of autophagy by cytosolic acetyl-coenzyme A.

artículo científico publicado en 2014

Regulation of autophagy by stress-responsive transcription factors

artículo científico

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set

artículo científico publicado en 2014

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

artículo científico publicado en 2018

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

artículo científico publicado en 2016

Trial Watch

artículo científico publicado en 2013

Trial Watch-Immunostimulation with cytokines in cancer therapy

artículo científico publicado en 2015

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

artículo científico publicado en 2013

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

artículo científico publicado en 2014

Trial Watch: Adoptive cell transfer immunotherapy

artículo científico publicado en 2012

Trial Watch: Anticancer radioimmunotherapy

artículo científico publicado en 2013

Trial Watch: Chemotherapy with immunogenic cell death inducers.

artículo científico publicado en 2014

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy

artículo científico publicado en 2012

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

artículo científico publicado en 2015

Trial Watch: Immunostimulatory cytokines

artículo científico publicado en 2012

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

artículo científico publicado en 2014

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

artículo científico publicado en 2016

Trial Watch: Lenalidomide-based immunochemotherapy

artículo científico publicado en 2013

Trial Watch: Monoclonal antibodies in cancer therapy

artículo científico publicado en 2012

Trial Watch: Peptide vaccines in cancer therapy

artículo científico publicado en 2013

Trial Watch: Toll-like receptor agonists for cancer therapy

artículo científico publicado en 2013

Trial Watch: Toll-like receptor agonists in oncological indications

artículo científico publicado en 2014

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

artículo científico publicado en 2014

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications

scientific article published on 21 July 2020

Trial watch: Cardiac glycosides and cancer therapy

artículo científico publicado en 2013

Trial watch: Chemotherapy with immunogenic cell death inducers

artículo científico publicado en 2012

Trial watch: Chemotherapy with immunogenic cell death inducers.

artículo científico publicado en 2013

Trial watch: DNA vaccines for cancer therapy

artículo científico publicado en 2013

Trial watch: Dendritic cell-based interventions for cancer therapy

artículo científico publicado en 2012

Trial watch: Dendritic cell-based interventions for cancer therapy

artículo científico publicado en 2013

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

artículo científico publicado en 2012

Trial watch: IDO inhibitors in cancer therapy

artículo científico publicado en 2014

Trial watch: IDO inhibitors in cancer therapy

scientific article published on 14 June 2020

Trial watch: Immunostimulatory cytokines in cancer therapy

artículo científico publicado en 2014

Trial watch: Monoclonal antibodies in cancer therapy

article by Erika Vacchelli et al published 1 January 2013 in OncoImmunology

Trial watch: Oncolytic viruses for cancer therapy

artículo científico publicado en 2013

Trial watch: Peptide vaccines in cancer therapy

artículo científico publicado en 2012

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer

artículo científico publicado en 2012

Trial watch: STING agonists in cancer therapy

artículo científico publicado en 2020

Trial watch: TLR3 agonists in cancer therapy

scientific article published on 02 June 2020

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

artículo científico publicado en 2015

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

scholarly article by David P Enot et al published 2018 in OncoImmunology

Vitamin B6 metabolism influences the intracellular accumulation of cisplatin

artículo científico publicado en 2012

Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1.

scientific article published on 30 March 2016

Lista de obras de Erika Vacchelli

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

Autophagy induction for the treatment of cancer

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

Cell death signaling and anticancer therapy

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Classification of current anticancer immunotherapies

Coffee induces autophagy in vivo

Consensus guidelines for the detection of immunogenic cell death

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

Contribution of annexin A1 to anticancer immunosurveillance

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Crosstalk between ER stress and immunogenic cell death

Current trends of anticancer immunochemotherapy

Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses

Fluorescent biosensors for the detection of HMGB1 release

Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Independent transcriptional reprogramming and apoptosis induction by cisplatin

Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer

Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo

Mitochondrial gateways to cancer

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19

Organs on chip approach: a tool to evaluate cancer -immune cells interactions

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Regulation of autophagy by cytosolic acetyl-coenzyme A.

Regulation of autophagy by stress-responsive transcription factors

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

Trial Watch

Trial Watch-Immunostimulation with cytokines in cancer therapy

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

Trial Watch: Adoptive cell transfer immunotherapy

Trial Watch: Anticancer radioimmunotherapy

Trial Watch: Chemotherapy with immunogenic cell death inducers.

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

Trial Watch: Immunostimulatory cytokines

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

Trial Watch: Lenalidomide-based immunochemotherapy

Trial Watch: Monoclonal antibodies in cancer therapy

Trial Watch: Peptide vaccines in cancer therapy

Trial Watch: Toll-like receptor agonists for cancer therapy

Trial Watch: Toll-like receptor agonists in oncological indications

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications

Trial watch: Cardiac glycosides and cancer therapy

Trial watch: Chemotherapy with immunogenic cell death inducers

Trial watch: Chemotherapy with immunogenic cell death inducers.

Trial watch: DNA vaccines for cancer therapy

Trial watch: Dendritic cell-based interventions for cancer therapy

Trial watch: Dendritic cell-based interventions for cancer therapy

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

Trial watch: IDO inhibitors in cancer therapy

Trial watch: IDO inhibitors in cancer therapy

Trial watch: Immunostimulatory cytokines in cancer therapy

Trial watch: Monoclonal antibodies in cancer therapy

Trial watch: Oncolytic viruses for cancer therapy

Trial watch: Peptide vaccines in cancer therapy

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer

Trial watch: STING agonists in cancer therapy